At a glance
ClinicalIndex Comparison RecordPhase 2Completed
Drug / intervention
paclitaxel coated balloon catheter (device with drug)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of in-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR II)
In Brief
A Phase 2 clinical trial evaluating paclitaxel coated balloon catheter (device with drug) for Coronary Restenosis. Completed, across 5 sites.
Detailed Summary
The PACCOCATH ISR II study is a randomized, double-blinded German multicenter trial on the efficacy and tolerance of a paclitaxel coated balloon catheter in coronary in-stent restenosis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Restenosis
CountriesGermany
Collaborators--
Timeline
Phase 2CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2004
Study CompletionJun 2006
First PostedDec 2006
TodayJul 2026
First PostedDec 12, 2006
Enrollment StartJul 1, 2004
Study CompletionJun 1, 2006
TodayJul 2, 2026
Posted 19.6 years ago
Interventions
paclitaxel coated balloon catheter (device with drug)device